BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.280
-0.260 (-5.73%)
At close: Apr 10, 2026, 4:00 PM EDT
4.450
+0.170 (3.97%)
After-hours: Apr 10, 2026, 7:34 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $30.73 million as of April 10, 2026. Its market cap has increased by 106.23% in one year.
Market Cap
30.73M
Enterprise Value
703.84K
1-Year Change
106.23%
Ranking
Category
Stock Price
$4.28
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $30.73M, an increase of 18.18%. That is a compound annual growth rate of 3.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 31.00M | 131.34% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pluri | 34.88M |
| Lixte Biotechnology Holdings | 34.62M |
| Actinium Pharmaceuticals | 33.98M |
| Longeveron | 33.97M |
| Plus Therapeutics | 33.56M |
| Evaxion | 33.28M |
| CEL-SCI | 33.18M |
| Dyadic International | 32.08M |